missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Levetiracetam, MedChemExpress
MedChemExpress Levetiracetam, an antiepileptic agent, binds the synaptic vesicle protein SV2A. Levetiracetam enhances Temozolomide effect on glioblastoma stem cell proliferation and apoptosis. Levetiracetam modulates HDAC levels ultimately silencing MGMT, thus increasing Temozolomide effectiveness. A chemosensitizer agent.
Brand: Medchem Express HY-B0106
This item is not returnable.
View return policy
Description
Levetiracetam, an antiepileptic agent, binds the synaptic vesicle protein SV2A. Levetiracetam enhances Temozolomide effect on glioblastoma stem cell proliferation and apoptosis. Levetiracetam modulates HDAC levels ultimately silencing MGMT, thus increasing Temozolomide effectiveness. A chemosensitizer agent.Specifications
| Levetiracetam | |
| White | |
| 50 mg | |
| H2O : ≥ 85 mg/mL (499.38 mM) ∣DMSO : ≥ 85 mg/mL (499.38 mM) | |
| 170.21 | |
| Research |
| 102767-28-2 | |
| Research | |
| UCB L059 | |
| NC([C@@H](N(CCC1)C1=O)CC)=O | |
| 99.21% | |
| Powder |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Levetiracetam, MedChemExpress
Research purposes only
Spot an opportunity for improvement?Share a Content Correction
